Indeed, GLUTag cells express the IL-6 receptor, and IL-6 treatment increases GLP-1 secretion in a dose-dependent manner, where acute IL-6 treatment increases GLP-1 exocytosis in a JAK2-STAT3-dependent manner, and chronic IL-6 treatment increases GLP-1 content and glucose uptake in a sodium glucose transporter 1-dependent manner in the L cell (Ellingsgaard et al., 2011)
doi:10.1097/CRD.0000000000000513 Kruse T, Hansen JL, Dahl K, et al
Retatrutide: Key Updates Clinicians Should Be Aware Of Obesity pharmacotherapy continues to evolve rapidly, and retatrutide represents one of the most important emerging developments clinicians should follow closely
Thats not the goal and not ideal long term
The 240-capsule count provides a 4-month supply at 2 capsules daily (2,000 mg) or an 8-month supply at 1 capsule daily (1,000 mg)
patient out-of-pocket expense may vary